Results 241 to 250 of about 6,501 (293)
Some of the next articles are maybe not open access.

Outpatient Cervical Ripening

Clinical Obstetrics and Gynecology, 1995
A limited number of studies have provided preliminary data on the efficacy and safety of PGE2 used as an outpatient cervical ripening agent. Multiple inpatient studies have confirmed the effect of PGE2 in favorably changing the cervical score, reducing the incidence of failed inductions and instrumental deliveries, shortening the induction-to-delivery ...
S K, Sawai, W F, O'Brien
openaire   +2 more sources

Cervical ripening with the Foley catheter

International Journal of Gynecology & Obstetrics, 2007
AbstractObjective: To evaluate maternal and neonatal outcomes in a large series of patients undergoing cervical ripening with a Foley catheter. Methods: The database of the Labor and Delivery Unit of the University of a teaching hospital in Italy was used to identify consecutive patients with a Bishop score (BS) of 4 or less who underwent pre‐induction
CROMI, ANTONELLA   +5 more
openaire   +3 more sources

Cervical Ripening

Clinical Obstetrics and Gynecology, 1998
In conclusion, no pharmacologic method presently used in the hospital to ripen the cervix has attained the level of standard of care for application in most office or clinic outpatient settings. Published data are accumulating that support the safety of the prostaglandin preparations for this purpose.
openaire   +2 more sources

Cervical ripening with dehydroepiandrosterone sulphate

BJOG: An International Journal of Obstetrics & Gynaecology, 1982
Summary. Dehydroepiandrosterone sulphate (DHEA‐S) was given intravenously twice a week after 38 weeks gestation to ripen the uterine cervix in 20 nulliparae and 24 parous women who subsequently went into labour at term. The condition of the uterine cervix was assessed by Bishop scoring.
K, Sasaki   +5 more
openaire   +2 more sources

Use of Misoprostol for Cervical Ripening

Southern Medical Journal, 2000
Misoprostol, the prostaglandin E1 analog, is increasingly used for cervical ripening and induction of labor. We evaluated our experience with misoprostol in an open-label setting.Patients were selected for cervical ripening based on clinical profile. At 3 cm cervical dilation, misoprostol was discontinued and other means of labor augmentation were used.
V L, Katz   +3 more
openaire   +2 more sources

Eosinophils in human cervical ripening

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
Cervical ripening has many similarities to an inflammatory reaction. Eosinophil granulocytes are involved in several inflammatory responses. The objective was to investigate the presence of eosinophils in human cervix uteri during different conditions.Cervical biopsies were obtained from non-pregnant (n = 6), women in early pregnancy (n = 11) and from ...
Knudsen, Ulla Breth   +3 more
openaire   +3 more sources

Inflammatory mediators and cervical ripening

Journal of Reproductive Immunology, 2002
The mechanisms which soften the cervix and allow it to dilate at birth are not well known. This is a crucial element in labour and current pharmacological approaches, largely the use of prostaglandins (PG), are only semi-selective for the cervix and can cause inappropriate myometrial contractions.
openaire   +2 more sources

Cervical ripening.

British journal of hospital medicine, 1983
When induction of labour is being considered the first step should be to assess the cervical score. If this is low, the gestational age should be confirmed since an unripe cervix is normal in earlier pregnancy and there may be a mistake in the patient's dates. If the maturity is confirmed, the choice lies between delivering the baby and waiting.
A J, Gordon, A A, Calder
openaire   +1 more source

Obesity and cervical ripening failure risk

The Journal of Maternal-Fetal & Neonatal Medicine, 2011
To estimate the impact of obesity on cervical ripening with prostaglandin E2 (PGE2).A retrospective study compared the cervical ripening efficiency of PGE2 on patients with BMI above 30 kg/m(2) and normal weight patients with BMI between 20 kg/m(2) and 25 kg/m(2). In case of a Bishop score (≤3), a dinoprostone tampon was used over 12 h.
Gauthier, Tristan   +6 more
openaire   +4 more sources

Anatomy and Physiology of Cervical Ripening

Clinical Obstetrics and Gynecology, 1995
The uterine cervix is a unique organ composed predominately of the extracellular matrix proteins, collagen, elastin, and glycosaminoglycans. During pregnancy and labor, this organ is metabolically active, which is rare in adult tissue. The metabolism is under reproductive hormonal control and is more complex than previously appreciated.
openaire   +2 more sources

Home - About - Disclaimer - Privacy